2025-01-01 2025-12-31 2025-12-31 false 10833705 THE GROWTH STAGE LIMITED 2026-02-20 74909 false iso4217:GBP xbrli:pure 10833705 2024-12-31 10833705 2025-12-31 10833705 2025-01-01 2025-12-31 10833705 2023-12-31 10833705 2024-12-31 10833705 2024-01-01 2024-12-31 10833705 bus:SmallEntities 2025-01-01 2025-12-31 10833705 bus:AuditExempt-NoAccountantsReport 2025-01-01 2025-12-31 10833705 bus:FullAccounts 2025-01-01 2025-12-31 10833705 bus:PrivateLimitedCompanyLtd 2025-01-01 2025-12-31 10833705 core:WithinOneYear 2025-12-31 10833705 core:AfterOneYear 2025-12-31 10833705 core:WithinOneYear 2024-12-31 10833705 core:AfterOneYear 2024-12-31 10833705 core:ShareCapital 2025-12-31 10833705 core:SharePremium 2025-12-31 10833705 core:RevaluationReserve 2025-12-31 10833705 core:OtherReservesSubtotal 2025-12-31 10833705 core:RetainedEarningsAccumulatedLosses 2025-12-31 10833705 core:ShareCapital 2024-12-31 10833705 core:SharePremium 2024-12-31 10833705 core:RevaluationReserve 2024-12-31 10833705 core:OtherReservesSubtotal 2024-12-31 10833705 core:RetainedEarningsAccumulatedLosses 2024-12-31 10833705 core:LandBuildings 2025-12-31 10833705 core:PlantMachinery 2025-12-31 10833705 core:Vehicles 2025-12-31 10833705 core:FurnitureFittings 2025-12-31 10833705 core:OfficeEquipment 2025-12-31 10833705 core:NetGoodwill 2025-12-31 10833705 core:IntangibleAssetsOtherThanGoodwill 2025-12-31 10833705 core:ListedExchangeTraded 2025-12-31 10833705 core:UnlistedNon-exchangeTraded 2025-12-31 10833705 core:LandBuildings 2024-12-31 10833705 core:PlantMachinery 2024-12-31 10833705 core:Vehicles 2024-12-31 10833705 core:FurnitureFittings 2024-12-31 10833705 core:OfficeEquipment 2024-12-31 10833705 core:NetGoodwill 2024-12-31 10833705 core:IntangibleAssetsOtherThanGoodwill 2024-12-31 10833705 core:ListedExchangeTraded 2024-12-31 10833705 core:UnlistedNon-exchangeTraded 2024-12-31 10833705 core:LandBuildings 2025-01-01 2025-12-31 10833705 core:PlantMachinery 2025-01-01 2025-12-31 10833705 core:Vehicles 2025-01-01 2025-12-31 10833705 core:FurnitureFittings 2025-01-01 2025-12-31 10833705 core:OfficeEquipment 2025-01-01 2025-12-31 10833705 core:NetGoodwill 2025-01-01 2025-12-31 10833705 core:IntangibleAssetsOtherThanGoodwill 2025-01-01 2025-12-31 10833705 core:ListedExchangeTraded 2025-01-01 2025-12-31 10833705 core:UnlistedNon-exchangeTraded 2025-01-01 2025-12-31 10833705 core:MoreThanFiveYears 2025-01-01 2025-12-31 10833705 core:Non-currentFinancialInstruments 2025-12-31 10833705 core:Non-currentFinancialInstruments 2024-12-31 10833705 dpl:CostSales 2025-01-01 2025-12-31 10833705 dpl:DistributionCosts 2025-01-01 2025-12-31 10833705 core:LandBuildings 2025-01-01 2025-12-31 10833705 core:PlantMachinery 2025-01-01 2025-12-31 10833705 core:Vehicles 2025-01-01 2025-12-31 10833705 core:FurnitureFittings 2025-01-01 2025-12-31 10833705 core:OfficeEquipment 2025-01-01 2025-12-31 10833705 dpl:AdministrativeExpenses 2025-01-01 2025-12-31 10833705 core:NetGoodwill 2025-01-01 2025-12-31 10833705 core:IntangibleAssetsOtherThanGoodwill 2025-01-01 2025-12-31 10833705 dpl:GroupUndertakings 2025-01-01 2025-12-31 10833705 dpl:ParticipatingInterests 2025-01-01 2025-12-31 10833705 dpl:GroupUndertakings core:ListedExchangeTraded 2025-01-01 2025-12-31 10833705 core:ListedExchangeTraded 2025-01-01 2025-12-31 10833705 dpl:GroupUndertakings core:UnlistedNon-exchangeTraded 2025-01-01 2025-12-31 10833705 core:UnlistedNon-exchangeTraded 2025-01-01 2025-12-31 10833705 dpl:CostSales 2024-01-01 2024-12-31 10833705 dpl:DistributionCosts 2024-01-01 2024-12-31 10833705 core:LandBuildings 2024-01-01 2024-12-31 10833705 core:PlantMachinery 2024-01-01 2024-12-31 10833705 core:Vehicles 2024-01-01 2024-12-31 10833705 core:FurnitureFittings 2024-01-01 2024-12-31 10833705 core:OfficeEquipment 2024-01-01 2024-12-31 10833705 dpl:AdministrativeExpenses 2024-01-01 2024-12-31 10833705 core:NetGoodwill 2024-01-01 2024-12-31 10833705 core:IntangibleAssetsOtherThanGoodwill 2024-01-01 2024-12-31 10833705 dpl:GroupUndertakings 2024-01-01 2024-12-31 10833705 dpl:ParticipatingInterests 2024-01-01 2024-12-31 10833705 dpl:GroupUndertakings core:ListedExchangeTraded 2024-01-01 2024-12-31 10833705 core:ListedExchangeTraded 2024-01-01 2024-12-31 10833705 dpl:GroupUndertakings core:UnlistedNon-exchangeTraded 2024-01-01 2024-12-31 10833705 core:UnlistedNon-exchangeTraded 2024-01-01 2024-12-31 10833705 core:NetGoodwill 2025-12-31 10833705 core:IntangibleAssetsOtherThanGoodwill 2025-12-31 10833705 core:LandBuildings 2025-12-31 10833705 core:PlantMachinery 2025-12-31 10833705 core:Vehicles 2025-12-31 10833705 core:FurnitureFittings 2025-12-31 10833705 core:OfficeEquipment 2025-12-31 10833705 core:AfterOneYear 2025-12-31 10833705 core:WithinOneYear 2025-12-31 10833705 core:ListedExchangeTraded 2025-12-31 10833705 core:UnlistedNon-exchangeTraded 2025-12-31 10833705 core:ShareCapital 2025-12-31 10833705 core:SharePremium 2025-12-31 10833705 core:RevaluationReserve 2025-12-31 10833705 core:OtherReservesSubtotal 2025-12-31 10833705 core:RetainedEarningsAccumulatedLosses 2025-12-31 10833705 core:NetGoodwill 2024-12-31 10833705 core:IntangibleAssetsOtherThanGoodwill 2024-12-31 10833705 core:LandBuildings 2024-12-31 10833705 core:PlantMachinery 2024-12-31 10833705 core:Vehicles 2024-12-31 10833705 core:FurnitureFittings 2024-12-31 10833705 core:OfficeEquipment 2024-12-31 10833705 core:AfterOneYear 2024-12-31 10833705 core:WithinOneYear 2024-12-31 10833705 core:ListedExchangeTraded 2024-12-31 10833705 core:UnlistedNon-exchangeTraded 2024-12-31 10833705 core:ShareCapital 2024-12-31 10833705 core:SharePremium 2024-12-31 10833705 core:RevaluationReserve 2024-12-31 10833705 core:OtherReservesSubtotal 2024-12-31 10833705 core:RetainedEarningsAccumulatedLosses 2024-12-31 10833705 core:NetGoodwill 2023-12-31 10833705 core:IntangibleAssetsOtherThanGoodwill 2023-12-31 10833705 core:LandBuildings 2023-12-31 10833705 core:PlantMachinery 2023-12-31 10833705 core:Vehicles 2023-12-31 10833705 core:FurnitureFittings 2023-12-31 10833705 core:OfficeEquipment 2023-12-31 10833705 core:AfterOneYear 2023-12-31 10833705 core:WithinOneYear 2023-12-31 10833705 core:ListedExchangeTraded 2023-12-31 10833705 core:UnlistedNon-exchangeTraded 2023-12-31 10833705 core:ShareCapital 2023-12-31 10833705 core:SharePremium 2023-12-31 10833705 core:RevaluationReserve 2023-12-31 10833705 core:OtherReservesSubtotal 2023-12-31 10833705 core:RetainedEarningsAccumulatedLosses 2023-12-31 10833705 core:AfterOneYear 2025-01-01 2025-12-31 10833705 core:WithinOneYear 2025-01-01 2025-12-31 10833705 core:Non-currentFinancialInstruments core:CostValuation 2025-01-01 2025-12-31 10833705 core:Non-currentFinancialInstruments core:AdditionsToInvestments 2025-01-01 2025-12-31 10833705 core:Non-currentFinancialInstruments core:RevaluationsIncreaseDecreaseInInvestments 2025-01-01 2025-12-31 10833705 core:Non-currentFinancialInstruments core:DisposalsDecreaseInInvestments 2025-01-01 2025-12-31 10833705 core:Non-currentFinancialInstruments core:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments 2025-01-01 2025-12-31 10833705 core:Non-currentFinancialInstruments core:ImpairmentLossReversalProvisionsForImpairmentInvestments 2025-01-01 2025-12-31 10833705 core:Non-currentFinancialInstruments core:AcquisitionsIncreaseInProvisionsForImpairmentInvestments 2025-01-01 2025-12-31 10833705 core:Non-currentFinancialInstruments core:DisposalsDecreaseInProvisionsForImpairmentInvestments 2025-01-01 2025-12-31 10833705 core:Non-currentFinancialInstruments core:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments 2025-01-01 2025-12-31 10833705 core:Non-currentFinancialInstruments core:CostValuation 2025-12-31 10833705 core:Non-currentFinancialInstruments core:AdditionsToInvestments 2025-12-31 10833705 core:Non-currentFinancialInstruments core:RevaluationsIncreaseDecreaseInInvestments 2025-12-31 10833705 core:Non-currentFinancialInstruments core:DisposalsDecreaseInInvestments 2025-12-31 10833705 core:Non-currentFinancialInstruments core:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments 2025-12-31 10833705 core:Non-currentFinancialInstruments core:ImpairmentLossReversalProvisionsForImpairmentInvestments 2025-12-31 10833705 core:Non-currentFinancialInstruments core:AcquisitionsIncreaseInProvisionsForImpairmentInvestments 2025-12-31 10833705 core:Non-currentFinancialInstruments core:DisposalsDecreaseInProvisionsForImpairmentInvestments 2025-12-31 10833705 core:Non-currentFinancialInstruments core:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments 2025-12-31 10833705 core:Non-currentFinancialInstruments core:CostValuation 2024-12-31 10833705 core:Non-currentFinancialInstruments core:AdditionsToInvestments 2024-12-31 10833705 core:Non-currentFinancialInstruments core:RevaluationsIncreaseDecreaseInInvestments 2024-12-31 10833705 core:Non-currentFinancialInstruments core:DisposalsDecreaseInInvestments 2024-12-31 10833705 core:Non-currentFinancialInstruments core:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments 2024-12-31 10833705 core:Non-currentFinancialInstruments core:ImpairmentLossReversalProvisionsForImpairmentInvestments 2024-12-31 10833705 core:Non-currentFinancialInstruments core:AcquisitionsIncreaseInProvisionsForImpairmentInvestments 2024-12-31 10833705 core:Non-currentFinancialInstruments core:DisposalsDecreaseInProvisionsForImpairmentInvestments 2024-12-31 10833705 core:Non-currentFinancialInstruments core:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments 2024-12-31 10833705 bus:Director1 2025-01-01 2025-12-31 10833705 bus:Director2 2025-01-01 2025-12-31 10833705 1 2025-01-01 2025-12-31

THE GROWTH STAGE LIMITED

Registered Number
10833705
(England and Wales)

Unaudited Financial Statements for the Year ended
31 December 2025

THE GROWTH STAGE LIMITED
Company Information
for the year from 1 January 2025 to 31 December 2025

Directors | ACTON, Andrew Simon
| STEWART, Simon Grahame John

Registered Address | 4th Floor 18 St Cross Street
| London
| EC1N 8UN

Registered Number | 10833705 (England and Wales)

THE GROWTH STAGE LIMITED
Statement of Financial Position
31 December 2025

| Notes | 2025 |  | 2024
--- | --- | --- | --- | ---
|  | £ |  | £ |  | £ |  | £
Fixed assets |  |  |  |  |  |  |  |
Investments | 3 |  |  | 227,009 |  |  |  | 227,009
|  |  |  | 227,009 |  |  |  | 227,009
Current assets |  |  |  |  |  |  |  |
Debtors | 5 | 4,372 |  |  |  | 4,842 |  |
Cash at bank and on hand |  | 481,139 |  |  |  | 230,599 |  |
|  | 485,511 |  |  |  | 235,441 |  |
Creditors amounts falling due within one year | 6 | (178,939) |  |  |  | (26,596) |  |
Net current assets (liabilities) |  |  |  | 306,572 |  |  |  | 208,845
Total assets less current liabilities |  |  |  | 533,581 |  |  |  | 435,854
Net assets |  |  |  | 533,581 |  |  |  | 435,854
Capital and reserves |  |  |  |  |  |  |  |
Called up share capital |  |  |  | 20,026 |  |  |  | 20,026
Share premium |  |  |  | 180,967 |  |  |  | 180,967
Other reserves |  |  |  | (79,747) |  |  |  | (79,747)
Profit and loss account |  |  |  | 412,335 |  |  |  | 314,608
Shareholders' funds |  |  |  | 533,581 |  |  |  | 435,854

- The company was entitled to exemption from audit for this reporting period under section 477 of the Companies Act 2006 relating to small companies.
- The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
- The Directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
- These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.
- The directors have chosen to not file a copy of the company’s profit and loss account under section 444 (5A) Companies Act 2006.

The financial statements were approved and authorised for issue by the Board of Directors on 20 February 2026, and are signed on its behalf by:
STEWART, Simon Grahame John Director Registered Company No. 10833705

THE GROWTH STAGE LIMITED
Notes to the Financial Statements
for the year ended 31 December 2025

1. | Accounting policies
--- | ---

| Statutory information
--- | ---
| The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

| Statement of compliance
--- | ---
| The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.

| Basis of preparation
--- | ---
| The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).

| Functional and presentation currency
--- | ---
| The financial statements are presented in sterling and this is the functional currency of the company.

| Turnover policy
--- | ---
| Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the rendering of services.

| Revenue from rendering of services
--- | ---
| Turnover is usually recognised on completion of the service, and for monthly engagements, it is recognised by reference to the stage of completion at the balance sheet date.

| Foreign currency translation
--- | ---
| Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.

| Current taxation
--- | ---
| Current tax is recognised on taxable profit for the current and past periods. Current tax represents the amount of tax payable (receivable) in respect of taxable profit (loss) for the current, or past, reporting periods. Current tax is measured at the amount expected to be paid (recovered) using the tax rates and laws which have been enacted, or substantively enacted, by the balance sheet date. Where payments to HM Revenue and Customs exceed liabilities owed, an asset is recognised to the extent of the amount of tax recoverable.

| Deferred tax
--- | ---
| Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.

| Research and development
--- | ---
| All research costs are expensed. Costs related to the development of products are capitalised when they meet the criteria stated in FRS 102, Section 18 Intangible assets other than Goodwill. All other development expenditure is recognised as an expense in the period in which it is incurred.

| Investments
--- | ---
| Investments in subsidiaries, associates and joint ventures are measured at cost less any accumulated impairment losses. Listed investments are measured at fair value where the difference between cost and fair value is material. Unlisted investments are measured at fair value unless the value cannot be measured reliably, in which case they are measured at cost less any accumulated impairment losses. Changes in fair value are included in the profit and loss account.

2. | Average number of employees
--- | ---

|  | 2025 |  | 2024
| Average number of employees during the year | 2 |  | 2

3. | Fixed asset investments
--- | ---

|  | Other investments1 |  | Other loans2 |  | Total
--- | --- | --- | --- | --- | --- | ---
|  | £ |  | £ |  | £
| Cost or valuation
| At 01 January 25 | 20,008 |  | 207,001 |  | 227,009
| At 31 December 25 | 20,008 |  | 207,001 |  | 227,009
| Net book value
| At 31 December 25 | 20,008 |  | 207,001 |  | 227,009
| At 31 December 24 | 20,008 |  | 207,001 |  | 227,009

| Notes
--- | ---
| 1Other investments other than loans 2Other loans classified under investments

4. | Impairment of fixed asset investments
--- | ---
| A review for indicators of impairment is conducted at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date.

5. | Debtors: amounts due within one year
--- | ---

|  | 2025 |  | 2024
--- | --- | --- | --- | ---
|  | £ |  | £
| Other debtors | 4,372 |  | 4,842
| Total | 4,372 |  | 4,842

| Short-term debtors are measured at transaction price (which is usually the invoice price), less impairment losses for bad and doubtful debts.

6. | Creditors: amounts due within one year
--- | ---

|  | 2025 |  | 2024
--- | --- | --- | --- | ---
|  | £ |  | £
| Trade creditors / trade payables | 113 |  | 24,056
| Taxation and social security | 33,926 |  | 2,540
| Accrued liabilities and deferred income | 144,900 |  | -
| Total | 178,939 |  | 26,596

| Short term creditors are measured at transaction price (which is usually the invoice price).

7. | Events after reporting date
--- | ---
| At the date of signature of these financial statements there were no post balance sheet events (2024 – None).

8. | Related party transactions
--- | ---
| The amount outstanding at the balance sheet date in relation to advances to directors was £0 (2024 – £0).

9. | Further information regarding the company's financial position
--- | ---
| The company acquired its own shares from a shareholder during 2024. These shares have not been cancelled and are held in treasury.